Merck, Isomorphic Labs partner to develop oncology drug candidates

Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.
This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.
Read the full story at STAT ↗statnews.com
More from the Health desk
Just in

STAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatment

Call for corporate homicide probe over claims NHS Grampian patients unnecessarily bled to death

Measles has come raging back in the US. Robert F Kennedy Jr should be impeached | Judith Levine
